![](https://images.news18.com/ibnlive/uploads/2021/05/1622464291_covid-vaccines.jpg)
The recommendations are learnt to have been approved by the DCGI. In August 2020, US-based vaccine maker Novavax Inc. had announced a licence agreement with the SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
from Top India News- News18.com https://ift.tt/3qDGQll
via
Click here
Comments
Post a Comment